Checking type 1 diabetes risk using routine child care
Part of Digestive system, Hormones & metabolism, Immune system & allergy clinical trials.
This study estimates the chance of developing type 1 diabetes in children by using information gathered during regular well-child visits. It may help identify children who could benefit from earlier monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are receiving routine well-child care at a Sanford clinic or hospital
- Your child’s age fits one of these groups: newborn (term), under 6, ages 9–16, or a sibling age 6–17
- Your parent/guardian (or you, for eligible newborn situations) can sign consent before active labor (newborn group) or otherwise consent for the study
- You can use MyChart with proxy access (active MyChart account)
- Your child does not already have type 1 diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a program of diet and activity advice for families can lower the risk of type 1 diabetes in infants who have a higher genetic chance of developing it. It aims to find simple, everyday ways to help protect your child.
This study screens children’s blood to look for signs of celiac disease and type 1 diabetes. It may help doctors understand who is developing these conditions early.
This trial is looking for children with newly diagnosed type 1 diabetes to study how to detect the condition earlier. It focuses on kids who have already reached the stage where symptoms appear, to improve understanding of the disease.
This study screens brothers, sisters, and children of people with type 1 diabetes to find early signs of the disease before symptoms appear. The goal is to catch it early and offer monitoring or future prevention options.
This study screens high-risk children for early signs of type 1 diabetes by testing relatives who already have the condition. It aims to catch diabetes early so treatment can start sooner.
This study looks at immune cells in children who were recently diagnosed with type 1 diabetes. It involves one extra blood draw to better understand how the immune system attacks the pancreas. If you join, no new treatments are given—just observation and analysis of your child's immune cells.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.